Loading...
•
Sep 30, 2021
Conmed Q3 2021 Earnings Report
CONMED faced a challenging macro environment but demonstrated organizational resilience, growing revenue over the third quarters of both 2020 and 2019.
Key Takeaways
CONMED Corporation announced its third quarter financial results, highlighting revenue growth compared to the third quarters of 2020 and 2019, despite facing a challenging macro environment. The company is now targeting the lower end of its previously issued full-year 2021 revenue guidance and expects full-year 2021 adjusted diluted net earnings per share to be in the range of $3.18 to $3.23.
CONMED's revenue grew despite a challenging macro environment.
The company is targeting the lower end of its previously issued full-year 2021 revenue guidance.
CONMED expects approximately 100 basis points of foreign exchange headwind to fourth quarter revenue growth.
Full-year 2021 adjusted diluted net earnings per share are expected to be in the range of $3.18 to $3.23.
Forward Guidance
Given the continued uncertainty related to the global pandemic and the impact on hospitals, the Company is now targeting the lower end of its previously issued full-year 2021 revenue guidance of $1.015 billion to $1.035 billion. Based on recent exchange rates, the Company expects approximately 100 basis points of foreign exchange headwind to fourth quarter revenue growth. The Company now expects full-year 2021 adjusted diluted net earnings per share in the range of $3.18 to $3.23, compared to its prior range of $3.15 to $3.25.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...